GSK (GSK) Tops Q4 Earnings and Revenue Estimates - MSN

GSK (GSK) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.72 per share a year ago. These …


Install CouponFollow Chrome Extension   CouponFollow Extension

$0.59
OFF

GSK (GSK) Tops Q4 Earnings And Revenue Estimates - MSN

2 weeks from now

GSK (GSK) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.72 per share a year ago. These …

msn.com

$0.59
OFF

GSK (GSK) Tops Q4 Earnings And Revenue Estimates

2 weeks from now

3 days ago  · GSK (GSK Quick Quote GSK - Free Report) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to …

zacks.com

3%
OFF

GSK Beats Q4 Earnings Estimates, Lifts 2031 Sales Target - MSN

2 weeks from now

(Reuters) - GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines ...

msn.com

23%
OFF

Full-year And Fourth Quarter 2024 - GSK

2 weeks from now

2024 Q4 2024 £m AER CER £m AER CER Trelegy 2,702 23% 27% 669 14% 17% Trelegy is the most prescribed SITT(1) treatment worldwide for COPD and asthma. Sales grew 27% in the …

gsk.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - MSN

2 weeks from now

GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. However, adjusted earnings per share came in at £0.23, below the £0.49 analysts were …

msn.com

$0.64
OFF

GSK (GSK) Q4 Earnings And Revenues Top Estimates - Nasdaq

2 weeks from now

Feb 1, 2023  · GSK (GSK) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.86 per share a year …

nasdaq.com

2%
OFF

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

2 days ago  · In 2030, the latest year for which FactSet provides estimates, analysts currently project $45.52 billion in sales. In response, GSK stock surged 8.2% to close at 37.70.

investors.com

3%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

2 weeks from now

Jan 13, 2025  · Central New Jersey’s office market showed signs of stabilization in the fourth quarter of 2024, with new leasing activity rising 8.3% from the previous quarter after two …

cushmanwakefield.com

8%
OFF

GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …

2 weeks from now

Its 23.2 pence ($0.29) core earnings per share (EPS) for the fourth quarter and revenue of 8.12 billion pounds also beat estimates. GSK's U.S.-listed shares were up around 8% by midday …

msn.com

3%
OFF

GSK Q4 2024 Earnings Preview - MSN

2 weeks from now

GSK (NYSE:GSK) is scheduled to announce Q4 earnings results on Wednesday, February 5th, before market open. The consensus EPS Estimate is $0.49 (-98.3% Y/Y) and the consensus …

msn.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension